BACKGROUND AND PURPOSE: VBM is increasingly used in the study of neurodegeneration, and recently there has been interest in its potential as a biomarker. However, although it is largely "automated," VBM is rarely implemented consistently across studies, and changing user-specified options can alter the results in a way similar to the very biologic differences under investigation. MATERIALS AND METHODS: This work uses data from patients with HD to demonstrate the effects of several user-specified VBM parameters and analyses: type and level of statistical correction, modulation, smoothing kernel size, adjustment for brain size, subgroup analysis, and software version. RESULTS: The results demonstrate that changing these options can alter results in a way similar to the biologic differences under investigation. CONCLUSIONS: If VBM is to be useful clinically or considered for use as a biomarker, there is a need for greater recognition of these issues and more uniformity in its application for the method to be both reproducible and valid.
BACKGROUND AND PURPOSE: VBM is increasingly used in the study of neurodegeneration, and recently there has been interest in its potential as a biomarker. However, although it is largely "automated," VBM is rarely implemented consistently across studies, and changing user-specified options can alter the results in a way similar to the very biologic differences under investigation. MATERIALS AND METHODS: This work uses data from patients with HD to demonstrate the effects of several user-specified VBM parameters and analyses: type and level of statistical correction, modulation, smoothing kernel size, adjustment for brain size, subgroup analysis, and software version. RESULTS: The results demonstrate that changing these options can alter results in a way similar to the biologic differences under investigation. CONCLUSIONS: If VBM is to be useful clinically or considered for use as a biomarker, there is a need for greater recognition of these issues and more uniformity in its application for the method to be both reproducible and valid.
Authors: Jane S Paulsen; Vince A Magnotta; Ania E Mikos; Henry L Paulson; Elizabeth Penziner; Nancy C Andreasen; Peg C Nopoulos Journal: Biol Psychiatry Date: 2005-08-22 Impact factor: 13.382
Authors: G Douaud; V Gaura; M-J Ribeiro; F Lethimonnier; R Maroy; C Verny; P Krystkowiak; P Damier; A-C Bachoud-Levi; P Hantraye; P Remy Journal: Neuroimage Date: 2006-07-27 Impact factor: 6.556
Authors: Andrew Feigin; Maria-Felice Ghilardi; Chaorui Huang; Yilong Ma; Maren Carbon; Mark Guttman; Jane S Paulsen; Claude P Ghez; David Eidelberg Journal: Ann Neurol Date: 2006-01 Impact factor: 10.422
Authors: Robert K McClure; Ingrid Phillips; Roukan Jazayerli; Allan Barnett; Richard Coppola; Daniel R Weinberger Journal: Psychiatry Res Date: 2006-11-09 Impact factor: 3.222
Authors: Jan Kassubek; G Bernhard Landwehrmeyer; Daniel Ecker; Freimut D Juengling; Rainer Muche; Sabine Schuller; Adolf Weindl; Alexander Peinemann Journal: Neuroreport Date: 2004-02-09 Impact factor: 1.837
Authors: J Kassubek; F D Juengling; T Kioschies; K Henkel; J Karitzky; B Kramer; D Ecker; J Andrich; C Saft; P Kraus; A J Aschoff; A C Ludolph; G B Landwehrmeyer Journal: J Neurol Neurosurg Psychiatry Date: 2004-02 Impact factor: 10.154
Authors: Larry J Seidman; Joseph Biederman; Lichen Liang; Eve M Valera; Michael C Monuteaux; Ariel Brown; Jonathan Kaiser; Thomas Spencer; Stephen V Faraone; Nikos Makris Journal: Biol Psychiatry Date: 2010-12-23 Impact factor: 13.382
Authors: Hans-Peter Müller; Volkmar Glauche; Marianne J U Novak; Thao Nguyen-Thanh; Alexander Unrath; Nayana Lahiri; Joy Read; Miranda Julia Say; Sarah J Tabrizi; Jan Kassubek; Stefan Kloppel Journal: PLoS Curr Date: 2011-06-07
Authors: Rachael G Grazioplene; Sephira G Ryman; Jeremy R Gray; Aldo Rustichini; Rex E Jung; Colin G DeYoung Journal: Hum Brain Mapp Date: 2014-12-09 Impact factor: 5.038
Authors: Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers Journal: Psychiatry Res Neuroimaging Date: 2018-08-03 Impact factor: 2.376
Authors: Ardesheer Talati; Spiro P Pantazatos; Franklin R Schneier; Myrna M Weissman; Joy Hirsch Journal: Biol Psychiatry Date: 2012-06-29 Impact factor: 13.382